Literature DB >> 15114470

Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes.

D Tripathy1, K F Eriksson, M Orho-Melander, J Fredriksson, G Ahlqvist, L Groop.   

Abstract

AIMS/HYPOTHESIS: The aim of the study was to evaluate the relationship between insulin sensitivity, beta cell function and glucose tolerance, and its dependence on variants in the newly identified Type 2 diabetes susceptibility gene, calpain-10 ( CAPN10).
METHODS: We studied 203 men of the same age but with varying degrees of glucose tolerance. These men participated in (i) an oral glucose tolerance test, (ii) a euglycaemic clamp combined with indirect calorimetry and infusion of [3-(3)H]-glucose and (iii) a stepwise assessment of acute insulin response to arginine (AIR) at three different glucose concentrations (fasting, 14 and 28 mmol/l).
RESULTS: There was a linear increase in NEFA levels ( p<0.0005) and WHR ( p<0.0005) and decrease in glucose uptake due to a reduction in glucose storage over the entire range of glucose tolerance ( r=-0.404; p<0.005). No increase in endogenous glucose production (EGP) was seen until patients had manifest diabetes. However, when EGP was expressed relative to fasting insulin concentrations, there was a linear deterioration of basal hepatic insulin sensitivity ( r=-0.514; p<0.005). The AIR followed a bell-shaped curve with an initial rise and subsequent decrease. However, AIR adjusted for insulin sensitivity (disposition index) showed a linear decrease with increasing glucose concentrations ( r=-0.563; p<0.001) starting already in subjects with normal glucose tolerance. There was an inverse correlation between increase in WHR and NEFA and peripheral as well as hepatic insulin sensitivity. Subjects with the genotype combination of CAPN10 consisting of SNP44 TT and SNP43 GG genotypes had significantly lower insulin-stimulated glucose uptake than carriers of the other genotype combinations (5.3+/-0.4 vs 7.2+/-0.4 mg.ffm kg(-1).min(-1).mU.l(-1); p<0.005). CONCLUSIONS/
INTERPRETATION: We conclude that the pre-diabetic state is characterised by a similar linear deterioration of peripheral and hepatic insulin sensitivity as beta cell function and that variants in the CAPN10 gene modify this relationship. These findings are compatible with a common defect in muscle, liver and beta cells in the pathogenesis of Type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114470     DOI: 10.1007/s00125-004-1393-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  53 in total

1.  Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells.

Authors:  H Mulder; L S Holst; H Svensson; E Degerman; F Sundler; B Ahrén; P Rorsman; C Holm
Journal:  Diabetes       Date:  1999-01       Impact factor: 9.461

2.  Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.

Authors:  D Tripathy; A L Carlsson; M Lehto; B Isomaa; T Tuomi; L Groop
Journal:  Diabetologia       Date:  2000-12       Impact factor: 10.122

3.  Calpains play a role in insulin secretion and action.

Authors:  S K Sreenan; Y P Zhou; K Otani; P A Hansen; K P Currie; C Y Pan; J P Lee; D M Ostrega; W Pugh; Y Horikawa; N J Cox; C L Hanis; C F Burant; A P Fox; G I Bell; K S Polonsky
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

4.  Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians.

Authors:  Søren K Rasmussen; Søren A Urhammer; Lars Berglund; Jan N Jensen; Lars Hansen; Søren M Echwald; Knut Borch-Johnsen; Yukio Horikawa; Hirosato Mashima; Hans Lithell; Nancy J Cox; Torben Hansen; Graeme I Bell; Oluf Pedersen
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

5.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.

Authors:  G W Cline; K F Petersen; M Krssak; J Shen; R S Hundal; Z Trajanoski; S Inzucchi; A Dresner; D L Rothman; G I Shulman
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

6.  A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance.

Authors:  L J Baier; P A Permana; X Yang; R E Pratley; R L Hanson; G Q Shen; D Mott; W C Knowler; N J Cox; Y Horikawa; N Oda; G I Bell; C Bogardus
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

7.  Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients.

Authors:  J Pigon; A Giacca; C G Ostenson; L Lam; M Vranic; S Efendic
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM.

Authors:  C Y Jeng; W H Sheu; M M Fuh; Y D Chen; G M Reaven
Journal:  Diabetes       Date:  1994-12       Impact factor: 9.461

10.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity.

Authors:  A Dresner; D Laurent; M Marcucci; M E Griffin; S Dufour; G W Cline; L A Slezak; D K Andersen; R S Hundal; D L Rothman; K F Petersen; G I Shulman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more
  31 in total

1.  Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.

Authors:  Cullen M Taniguchi; Kohjiro Ueki; Ronald Kahn
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 2.  [Genetics of type 2 diabetes].

Authors:  Y Böttcher; P Kovacs; A Tönjes; M Stumvoll
Journal:  Internist (Berl)       Date:  2005-07       Impact factor: 0.743

3.  Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.

Authors:  Cullen M Taniguchi; Thien T Tran; Tatsuya Kondo; Ji Luo; Kohjiro Ueki; Lewis C Cantley; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

4.  Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.

Authors:  Valeriya Lyssenko; Roberto Lupi; Piero Marchetti; Silvia Del Guerra; Marju Orho-Melander; Peter Almgren; Marketa Sjögren; Charlotte Ling; Karl-Fredrik Eriksson; Asa-Linda Lethagen; Rita Mancarella; Göran Berglund; Tiinamaija Tuomi; Peter Nilsson; Stefano Del Prato; Leif Groop
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 5.  Accelerating drug development using biomarkers: a case study with sitagliptin, a novel DPP4 inhibitor for type 2 diabetes.

Authors:  Rajesh Krishna; Gary Herman; John A Wagner
Journal:  AAPS J       Date:  2008-08-07       Impact factor: 4.009

6.  ABCA1 in adipocytes regulates adipose tissue lipid content, glucose tolerance, and insulin sensitivity.

Authors:  Willeke de Haan; Alpana Bhattacharjee; Piers Ruddle; Martin H Kang; Michael R Hayden
Journal:  J Lipid Res       Date:  2014-01-17       Impact factor: 5.922

7.  Short-term exercise improves beta-cell function and insulin resistance in older people with impaired glucose tolerance.

Authors:  Cathie J Bloem; Annette M Chang
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

8.  Effect of short-term free Fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals.

Authors:  Alberto O Chavez; Subhash Kamath; Rucha Jani; Lokendra K Sharma; Adriana Monroy; Muhammad A Abdul-Ghani; Victoria E Centonze; Padma Sathyanarayana; Dawn K Coletta; Cristopher P Jenkinson; Yidong Bai; Franco Folli; Ralph A Defronzo; Devjit Tripathy
Journal:  J Clin Endocrinol Metab       Date:  2009-10-28       Impact factor: 5.958

9.  Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes.

Authors:  Charlotte Ling; Leif Groop; Silvia Del Guerra; Roberto Lupi
Journal:  PLoS One       Date:  2009-08-18       Impact factor: 3.240

Review 10.  Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.

Authors:  Ralph A DeFronzo; Devjit Tripathy
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.